These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetically enhancing the expression of chemokine domain of CX Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780 [TBL] [Abstract][Full Text] [Related]
4. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice. Winter AN; Subbarayan MS; Grimmig B; Weesner JA; Moss L; Peters M; Weeber E; Nash K; Bickford PC J Neuroinflammation; 2020 May; 17(1):157. PubMed ID: 32410624 [TBL] [Abstract][Full Text] [Related]
5. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Nash KR; Lee DC; Hunt JB; Morganti JM; Selenica ML; Moran P; Reid P; Brownlow M; Guang-Yu Yang C; Savalia M; Gemma C; Bickford PC; Gordon MN; Morgan D Neurobiol Aging; 2013 Jun; 34(6):1540-8. PubMed ID: 23332170 [TBL] [Abstract][Full Text] [Related]
6. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
7. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Lastres-Becker I; Innamorato NG; Jaworski T; Rábano A; Kügler S; Van Leuven F; Cuadrado A Brain; 2014 Jan; 137(Pt 1):78-91. PubMed ID: 24277722 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia. Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423 [TBL] [Abstract][Full Text] [Related]
9. Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1. Finneran D; Li Q; Subbarayan MS; Joly-Amado A; Kamath S; Dengler DG; Gordon MN; Jackson MR; Morgan D; Bickford PC; Smith LH; Nash KR Glia; 2023 Feb; 71(2):245-258. PubMed ID: 36106533 [TBL] [Abstract][Full Text] [Related]
10. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin. Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996 [TBL] [Abstract][Full Text] [Related]
12. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice. Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432 [TBL] [Abstract][Full Text] [Related]
13. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy. Vagnozzi AN; Giannopoulos PF; Praticò D Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809 [TBL] [Abstract][Full Text] [Related]
14. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
15. Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina. Rodriguez D; Church KA; Pietramale AN; Cardona SM; Vanegas D; Rorex C; Leary MC; Muzzio IA; Nash KR; Cardona AE J Neuroinflammation; 2024 Feb; 21(1):42. PubMed ID: 38311721 [TBL] [Abstract][Full Text] [Related]
16. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina. Rodriguez D; Church KA; Smith CT; Vanegas D; Cardona SM; Muzzio IA; Nash KR; Cardona AE Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38339005 [TBL] [Abstract][Full Text] [Related]
18. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819 [TBL] [Abstract][Full Text] [Related]
19. Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Sheridan GK; Murphy KJ Open Biol; 2013 Dec; 3(12):130181. PubMed ID: 24352739 [TBL] [Abstract][Full Text] [Related]
20. Expression of the chemokine fractalkine (FKN/CX3CL1) by podocytes in normal and proteinuric rat kidney glomerulus. Katsuyama K; Fujinaka H; Yamamoto K; Nameta M; Yaoita E; Yoshida Y; Tomizawa S; Uchiyama M; Yamamoto T Nephron Exp Nephrol; 2009; 113(2):e45-56. PubMed ID: 19590241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]